The Wade-Martins Group conducts critical research into several neurodegenerative diseases, including Alzheimer's Disease, Parkinson's Disease and Friedreich's Ataxia, with the aim to understand the molecular mechanisms of these disorders and help develop new treatments.
Inside the Wade-Martins Lab for World Alzheimer’s Day 2022
Public Engagement Research Highlights
22 September 2022
This week DPAG marked World Alzheimer's Day, which took place on Wednesday 21 September 2022, with an inside look into the Wade-Martins Laboratory.